We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Healthcare Ent. | LSE:HCEG | London | Ordinary Share | GB00B6030H73 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMHCEG
RNS Number : 3732Y
Healthcare Enterprise Group PLC
21 December 2010
Healthcare Enterprise Group plc
("Healthcare" or the "Company")
Suspension of Trading in the Company's shares
Board change
In the Company's interim results, which were announced on 19 March 2010, the Company referred to the likelihood of a continued losses in the second half of the financial year and the need to raise further funds to continue to meet operating costs, albeit that these were being kept at a minimal level. In addition, the Company referred to a potential transaction following which the Company would cease to be an "investing Company" under the AIM Rules.
Unfortunately it has not been possible to complete this transaction and the costs incurred as a result, coupled with an inability to raise further equity funding, have further weakened the Company's balance sheet. Until the financial position is clarified, the Company will not be in a position to publish its audited accounts for the year to 30 June 2010, which would otherwise have to be released by 31 December 2010.
The Company has therefore requested that trading in its ordinary shares be suspended pending clarification of its financial position and until the 2010 audited accounts can be published. A further announcement will be made when possible.
The Company announces further that John Honey has resigned from the board with immediate effect to concentrate on running the Company's two investee companies, Ebiox Limited and Reproductive Sciences Limited.
Further Enquiries:
Healthcare Enterprise Group plc Tel: +44 (0)20 7680 3649 John Gunn, Lyndon Gaborit www.hcegroup.com Daniel Stewart & Company plc Tel: +44 (0)20 7776 6550 Antony Legge, Emma Earl
This information is provided by RNS
The company news service from the London Stock Exchange
END
SRSLLFEFFDLLFII
1 Year Healthcare Enterprise Chart |
1 Month Healthcare Enterprise Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions